| Artificial intelligence: A powerful paradigm for scientific research Y Xu, X Liu, X Cao, C Huang, E Liu, S Qian, X Liu, Y Wu, F Dong, CW Qiu, ... The Innovation 2 (4), 2021 | 1119 | 2021 |
| Carbohydrate-based drugs launched during 2000− 2021 X Cao, X Du, H Jiao, Q An, R Chen, P Fang, J Wang, B Yu Acta Pharmaceutica Sinica B 12 (10), 3783-3821, 2022 | 155 | 2022 |
| Towards the overcoming of anticancer drug resistance mediated by p53 mutations X Cao, J Hou, Q An, YG Assaraf, X Wang Drug Resistance Updates 49, 100671, 2020 | 149 | 2020 |
| Acquired resistance to third-generation EGFR-TKIs and emerging next-generation EGFR inhibitors X Du, B Yang, Q An, YG Assaraf, X Cao, J Xia The Innovation 2 (2), 2021 | 121 | 2021 |
| Prediction for global African swine fever outbreaks based on a combination of random forest algorithms and meteorological data R Liang, Y Lu, X Qu, Q Su, C Li, S Xia, Y Liu, Q Zhang, X Cao, Q Chen, ... Transboundary and emerging diseases 67 (2), 935-946, 2020 | 105 | 2020 |
| Single-cell technologies: From research to application L Wen, G Li, T Huang, W Geng, H Pei, J Yang, M Zhu, P Zhang, R Hou, ... The Innovation 3 (6), 2022 | 78 | 2022 |
| Role of miR‐221/222 in tumor development and the underlying mechanism Q Song, Q An, B Niu, X Lu, N Zhang, X Cao Journal of Oncology 2019 (1), 7252013, 2019 | 72 | 2019 |
| Inhibition of cancer stem cell like cells by a synthetic retinoid J Chen, X Cao, Q An, Y Zhang, K Li, W Yao, F Shi, Y Pan, Q Jia, W Zhou, ... Nature communications 9 (1), 1406, 2018 | 71 | 2018 |
| Marine drugs–macrolactins XL Lu, QZ Xu, XY Liu, X Cao, KY Ni, BH Jiao Chemistry & biodiversity 5 (9), 1669-1674, 2008 | 65 | 2008 |
| Progress in target drug molecules for Alzheimer's disease J Xie, R Liang, Y Wang, J Huang, X Cao, B Niu Current Topics in Medicinal Chemistry 20 (1), 4-36, 2020 | 48 | 2020 |
| Identifying cancer targets based on machine learning methods via Chou’s 5-steps rule and general pseudo components R Liang, J Xie, C Zhang, M Zhang, H Huang, H Huo, X Cao, B Niu Current topics in medicinal chemistry 19 (25), 2301-2317, 2019 | 36 | 2019 |
| Photo-induced copper-catalyzed alkynylation and amination of remote unactivated C (sp3)-H bonds Z Cao, J Li, Y Sun, H Zhang, X Mo, X Cao, G Zhang Chemical Science 12 (13), 4836-4840, 2021 | 34 | 2021 |
| A Newly Synthesized Rhamnoside Derivative Alleviates Alzheimer’s Amyloid‐β‐Induced Oxidative Stress, Mitochondrial Dysfunction, and Cell Senescence … Y Li, J Lu, X Cao, H Zhao, L Gao, P Xia, G Pei Oxidative Medicine and Cellular Longevity 2020 (1), 7698560, 2020 | 32 | 2020 |
| Marine antibody–drug conjugates: design strategies and research progress YJ Wang, YY Li, XY Liu, XL Lu, X Cao, BH Jiao Marine drugs 15 (1), 18, 2017 | 31 | 2017 |
| Diketopiperazine constituents of marine Bacillus subtilis X Lu, Y Shen, Y Zhu, Q Xu, X Liu, K Ni, X Cao, W Zhang, B Jiao Chemistry of natural compounds 45, 290-292, 2009 | 31 | 2009 |
| Amipurimycin: total synthesis of the proposed structures and diastereoisomers S Wang, J Sun, Q Zhang, X Cao, Y Zhao, G Tang, B Yu Angewandte Chemie 130 (11), 2934-2938, 2018 | 30 | 2018 |
| Synthesis of ocotillol-type ginsenosides R Shen, X Cao, S Laval, J Sun, B Yu The Journal of Organic Chemistry 81 (21), 10279-10294, 2016 | 27 | 2016 |
| Design and synthesis of 7-alkoxy-4-heteroarylamino-3-quinolinecarbonitriles as dual inhibitors of c-Src kinase and nitric oxide synthase X Cao, QD You, ZY Li, QL Guo, J Shang, M Yan, JW Chern, ML Chen Bioorganic & medicinal chemistry 16 (11), 5890-5898, 2008 | 27 | 2008 |
| A brief perspective of drug resistance toward EGFR inhibitors: the crystal structures of EGFRs and their variants H Guan, Y Du, Y Ning, X Cao Future Medicinal Chemistry 9 (7), 693-704, 2017 | 24 | 2017 |
| Microwave-assisted simple synthesis of substituted 4-quinolone derivatives X Cao, QD You, ZY Li, Y Yang, XJ Wang Synthetic Communications® 39 (24), 4375-4383, 2009 | 23 | 2009 |
